BioSpace News Archive

Patient Enrolment Completed in MedAlliance PRESTIGE Below-the-Knee Clinical Trial

MedAlliance has announced completion of patient enrolment in the PRESTIGE* Below-the-Knee clinical trial.

January 15, 2020
·
3 min read
Business

ADC Therapeutics Appoints Joseph Camardo, MD, as Head of Medical Affairs

Former Celgene and Wyeth leader with 30 years of global biopharmaceutical experience joins company as it prepares for first Biologics License Application (BLA) submission

January 15, 2020
·
3 min read
Business

MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab

MorphoSys AG and Incyte Corporation announced that the companies have entered into a collaboration and license agreement to further develop and commercialize MorphoSys’ proprietary anti-CD19 antibody tafasitamab globally.

January 15, 2020
·
12 min read
Policy

The ICR responds to approval of abiraterone as first-line treatment for advanced prostate cancer on the NHS in Scotland

The Institute of Cancer Research, London, strongly welcomes the recommendation by the Scottish Medicines Consortium to make the prostate cancer drug abiraterone, when given alongside hormone therapy, available to men with advanced prostate cancer as first-line treatment on the NHS in Scotland.

January 15, 2020
·
6 min read
The Oxford Science Park sponsors the OXBA Innovation Award for the fifth year

Oxfordshire companies which are progressing valuable innovations can apply now for The Oxford Science Park Innovation Award, one of 2020’s Oxfordshire Business Awards.

January 15, 2020
·
3 min read
Business

Candidates Take on Drug Prices During Democratic Debate

Candidates pointed out ways they would use the power of the federal government to lower the cost of medications in the United States.

January 15, 2020
·
3 min read
·
Alex Keown
Policy

Elizabeth Holmes’ Attorneys Urge Court to Ignore Patient-Related Charges in Indictment

In a filing this week, the government said that tens of thousands of patients received “unreliable blood tests,” which deprived them of money and placed their health at risk.

January 15, 2020
·
2 min read
·
Alex Keown
Deals

Medtech innovator Xyall wins €5M Series A financing for its unique high-tech molecular pathology laboratory solution

Xyall BV has been identified as a next-generation global innovator in molecular pathology, winning Series A seed investment of €5 million from investment partners Sioux Technologies, BOM Brabant Ventures, the Netherlands Enterprise Agency and other private investors.

January 15, 2020
·
4 min read
Business

Theragnostics Expands Team with Significant Appointments

Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, announces the appointments of Dr Alex Jackson as Head of Research and Development and of Archie Hale as Director of Clinical Operations.

January 15, 2020
·
2 min read
Business

GBA Group Pharma (ABF) Completes Expansion and Scale-Up Project in Anticipation of Brexit

Expansion makes the company one of the few in Europe capable of meeting Brexit-related demand for clients doing business in the EU

January 15, 2020
·
2 min read